Product NDC: | 0517-0955 |
Proprietary Name: | Olanzapine |
Non Proprietary Name: | Olanzapine |
Active Ingredient(s): | 10 mg/2mL & nbsp; Olanzapine |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-0955 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201741 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120627 |
Package NDC: | 0517-0955-01 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (0517-0955-01) > 2 mL in 1 VIAL, GLASS |
NDC Code | 0517-0955-01 |
Proprietary Name | Olanzapine |
Package Description | 1 VIAL, GLASS in 1 CARTON (0517-0955-01) > 2 mL in 1 VIAL, GLASS |
Product NDC | 0517-0955 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20120627 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | OLANZAPINE |
Strength Number | 10 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |